Discover 921 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 921
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Portland OR, Seattle WA, Los Angeles CA, La Jolla CA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT06787612
Phase2, Recruiting
A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies
for
Advanced Solid Tumors
Location: Portland OR
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06719362
Phase1, Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
for
Small Cell Lung Cancer Extensive Stage
Location: Portland OR, Santa Rosa CA, Aurora CO, Sioux Falls SD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07227597
Phase1, Phase2, Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for
Non-small Cell Lung Cancer
Location: Portland OR, Reno NV, San Francisco CA, Fresno CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07195695
Phase3, Recruiting
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: Portland OR, Seattle WA, Los Angeles CA, La Jolla CA,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of AVZO-021 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: Portland OR, Oklahoma City OK, Dallas TX, Cleveland OH,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05867251
Phase1, Phase2, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase1, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Portland OR, Seattle WA, West Valley City UT,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
for
Kidney Cancer
Location: Portland OR, Los Angeles CA, Maywood IL,
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT00301990
Phase2, Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for
Cervical Cancer
Location: Portland OR, Reno NV, Palo Alto CA, Los Angeles CA,
Sponsor: GOG Foundation
Sex: Female
Age: 18+
Code: NCT04831580
Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Portland OR, Aurora CO, Milwaukee WI, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase1, Phase2, Recruiting
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
for
NSCLC, Stage I
Location: Portland OR, Omaha NE, Minneapolis MN, Iowa City IA,
Sponsor: Greg Durm, MD
Sex: All
Age: 18+
Code: NCT04317534
Phase2, Recruiting
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor, Solid Tumor
Location: Portland OR, Duarte CA, Los Angeles CA, Houston TX,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05981703
Phase1, Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
for
Oropharyngeal Cancer
Location: Portland OR, Vancouver, Duarte CA, Corona CA, Winnipeg,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT05451004
Phase3, Recruiting
Endolumenal Partial Myotomy for Esophageal Motility Disorders
for
Esophageal Motility Disorders
Location: Portland OR
Sponsor: The Oregon Clinic
Sex: All
Age: 18 - 70+
Code: NCT01302301
Phase2, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Portland OR, Seattle WA, Duarte CA, Los Angeles CA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase1, Phase2, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Portland OR, Salem OR, Tacoma WA, Redmond OR, Bend OR,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase3, Recruiting
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Portland OR, Dallas TX, Skokie IL, Ann Arbor MI,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06731478
Phase3, Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors